← FDA Drug Approvals (Drugs@FDA)
XYZAL
NDA · New Drug Application · Sponsor: CHATTEM SANOFI · Approved 2007-05-25
Drug application
- FDA Application #
NDA022064- Application type
- New Drug Application
- Brand name
- XYZAL
- Generic name
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CHATTEM SANOFI
- Manufacturer
- Chattem, Inc.
- First approval
- 2007-05-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown